Health News
FDA Approves Vitrakvi for Cancers With Certain Genetic Trait
11/28/2018
TUESDAY, Nov. 27, 2018 — Vitrakvi (larotrectinib) has been approved by the U.S. Food and Drug Administration to treat adult and pediatric patients whose cancers have a specific
Read More
